Skip to content
MedsAcross

Medicine

Aminocaproic acid 500 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Aminocaproic acid 500 mg tablet is a generic prescription medicine for oral use, made by 10 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Do Not Freeze. Store at 20°C to 25°C (68°F to 77°F).

Key facts

Active ingredient (INN)
Aminocaproic acid
Brand
Sold under the generic name
Strength
500 mg
Dosage form
Tablet
Route
Oral
Packs
30 tablets, 100 tablets, 30 blister pack and 8 more
Manufacturers
BioconIndiaNovadoz PharmaceuticalsIndiaVitruvias TherapeuticsAmerican Health PackagingAmneal PharmaceuticalsBlu PharmaceuticalsCarnegie PharmaceuticalsKesin PharmaMajor PharmaceuticalsRising Pharma Holdings
Origin register
US FDA, United States
Storage
Do Not Freeze. Store at 20°C to 25°C (68°F to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
B02AA01 Aminocaproic acid
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
3 December 2018
Identifiers
RxCUI 197351, 476271DailyMed set ID 5e5ebfcb-c3a2-1fcf-e063-6394a90a356a, 7d08ad63-71f5-4286-9622-84295668a293, 4a22e559-2dac-42d7-af8d-eb0ebbc2f76d +7NDC 81033-033, 24658-798, 69238-1637 +7Application ANDA212938, ANDA213928, ANDA212492 +2

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
30 tablet in 1 bottle70377-102-11BioconIndia15 March 2021
30 tablet in 1 bottle72205-049-30Novadoz PharmaceuticalsIndia10 December 2020
30 tablet in 1 bottle, plastic69238-1637-3Amneal Pharmaceuticals30 November 2019
30 tablet in 1 bottle24658-798-30Blu Pharmaceuticals24 January 2023
30 tablet in 1 bottle80005-128-08Carnegie Pharmaceuticals15 March 2021
30 tablet in 1 bottle16571-326-03Rising Pharma Holdings20 September 2026
100 tablet in 1 bottle69680-115-00Vitruvias Therapeutics3 December 2018
30 tablet in 1 bottle69680-115-30Vitruvias Therapeutics3 December 2018
30 blister pack in 1 carton / 1 tablet in 1 blister pack60687-739-25American Health Packaging10 March 2023
3 blister pack in 1 carton / 30 tablet in 1 blister pack81033-033-31Kesin Pharma2 November 2026
30 blister pack in 1 carton / 1 tablet in 1 blister pack0904-7165-07Major Pharmaceuticals30 November 2019

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 3 June 1964Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Aminocaproic acid

Clinical summary

Aminocaproic acid is an antifibrinolytic agent. It is available as tablets, oral solution and injection for intravenous use. MedsAcross supplies Aminocaproic acid for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Aminocaproic acid

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Aminocaproic acid 500 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.